Stay updated with breaking news from Double Stuff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Can GLP-1 drugs for obesity and diabetes, like Ozempic and Wegovy, help change the food industry? Consumers on these drugs experience a decline in their appetite and their appeal for sugary snacks filled with fats and sodium. Could this inspire consumer products companies to create healthier snacks?
Can GLP-1 drugs for obesity and diabetes, like Ozempic and Wegovy, help change the food industry? Consumers on these drugs experience a decline in their appetite and their appeal for sugary snacks filled with fats and sodium. Could this inspire consumer products companies to create healthier snacks?
The sun is shining and it’s not raining, but the wind is howling outside as I sit in my writing eyrie trying to come up with a column for this week.
I don't know anyone who doesn't love Oreos.
Oreo fans believe they’ve uncovered the latest and biggest scandal yet in “shrinkflation” across consumer goods — claiming that the crucial creme-to-cookie ratio has been quietly shrinking in their favorite snack.